PREVYMIS conc perf 240 mg/12ml flac
7680666530016
CH-66653
J05AX18
08.03.0.
1 / 3
google
Details
- Product number
- 6665301
- CPT
- -
- Packaging group
- 1
- Unit
- Durchstechflasche(n)
- Composition
- letermovirum 240 mg, hydroxypropylbetadexum 1800 mg, natrii chloridum, natrii hydroxidum, aqua ad iniectabile q.s. ad solutionem pro 12 ml corresp. natrium 22.9 mg.
Articles (1)
Prevymis 240 mg/12 ml, Konzentrat zur Herstellung einer Infusionslösung
Konzentrat
1
Official Swissmedic V2 data
Additional information from the official database
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
240.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
1800.0 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
22.9 MG | Substance | HBESI |
Reimbursement information
Public price
CHF 204.90
Specialties list
Yes
Generic
No
SL addition date:
01/11/2020
Authorization holder
MSD Merck Sharp & Dohme AG
6005 Luzern
Authorization information
- Swissmedic authorization number
- 66653
- Drug name
- Prevymis, Konzentrat zur Herstellung einer Infusionslösung
- Galenic form
- LSMP
- ATC Code
- J05AX18
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 05/04/2018
- Authorization expiration date
- 31/12/9999
- IT number
- 08.03.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- PREVYMIS 240 mg/12 ml sol inj 240 mg 1 pce
- Description (DE)
- PREVYMIS 240 mg/12 ml Inj Lös 240 mg 1 Stk
- Market launch
- 05/04/2018
- Narcotic (BTM)
- No